News

EMZ CONTINUES TO SUPPORT BIOGROUP’S EXTERNAL GROWTH STRATEGY

EMZ CONTINUES TO SUPPORT BIOGROUP’S EXTERNAL GROWTH STRATEGY

In October 2020, EMZ invested for the 5th time in Biogroup to support its acquisition of CMA-Médina, the leader on the Belgian market.

With more than 700 laboratories, Biogroup LCD is the leading player on the French routine medical biology market. Biogroup is held by its funder Stéphane Eimer, biologist.

In October 2020, Biogroup LCD made a significant step forward with its first acquisition in Europe, CMA-Medina, which enabled the group to become the number one player on the Belgian market

EMZ provided the necessary financing to complete this transforming acquisition, alongside ICG.